David T. Hagerty

Overview

David T. Hagerty received an average of $852K in total compensation, including $325K in salary, at Conatus Pharmaceuticals from 2014 to 2018.

Source: SEC filings on April 30, 2019, April 27, 2018, and April 28, 2015.

Related executives

We found nine more executives who work or worked at Conatus Pharmaceuticals.

Susan Knudson

Conatus Pharmaceuticals

Chief Financial Officer

Steven Mento

Conatus Pharmaceuticals

Chief Executive Officer

Joyce Reyes

Conatus Pharmaceuticals

Senior Vice President of Regulatory, Quality, Clinical Operations & Technical Operations

Richard Pascoe

Conatus Pharmaceuticals

Chief Executive Officer

Gail Naughton

Conatus Pharmaceuticals

Chief Scientific Officer

Keith Marshall

Conatus Pharmaceuticals

Chief Financial Officer

Alfred Spada

Conatus Pharmaceuticals

Chief Scientific Officer

Charles Cashion

Conatus Pharmaceuticals

Chief Financial Officer

News

You may also like